These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16263195)

  • 41. New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.
    Kamei K; Maeda N; Katsuragi-Ogino R; Koyama M; Nakajima M; Tatsuoka T; Ohno T; Inoue T
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2990-3. PubMed ID: 15914001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Tatarczyńska E; Nikiforuk A; Charakchieva-Minol S; Duszyńska B
    Pharmacol Rep; 2006; 58(1):107-14. PubMed ID: 16531637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ; Duszyńska B; Kołaczkowski M; Kowalski P; Kowalska T
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5863-6. PubMed ID: 15501057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.
    Kołaczkowski M; Zajdel P; Fhid O; Duszyńska B; Tatarczyńska E; Pawłowski M
    Pharmacol Rep; 2005; 57(2):229-35. PubMed ID: 15886422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Perrone R; Tortorella V
    J Pharm Pharmacol; 2004 Feb; 56(2):247-55. PubMed ID: 15005884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.
    Lacivita E; Leopoldo M; Masotti AC; Inglese C; Berardi F; Perrone R; Ganguly S; Jafurulla M; Chattopadhyay A
    J Med Chem; 2009 Dec; 52(23):7892-6. PubMed ID: 19705871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site.
    Mokrosz JL; Bojarski AJ; Maćkowiak M; Bielecka Z; Boksa J
    Pharmazie; 1994 May; 49(5):328-33. PubMed ID: 8016178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
    Ślifirski G; Król M; Kleps J; Podsadni P; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
    Eur J Med Chem; 2019 Oct; 180():383-397. PubMed ID: 31325785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
    Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.
    Mokrosz JL; Strekowski L; Duszyńska B; Harden DB; Mokrosz MJ; Bojarski AJ
    Pharmazie; 1994 Nov; 49(11):801-6. PubMed ID: 7838864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity.
    Zygmunt M; Sapa J; Chłoń-Rzepa G; Zagórska A; Siwek A; Pawłowski M; Nowak G
    Pharmacol Rep; 2014 Jun; 66(3):505-10. PubMed ID: 24905531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.
    Andronati S; Sava V; Makan S; Kolodeev G
    Pharmazie; 1999 Feb; 54(2):99-101. PubMed ID: 10084155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3-[(Aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter.
    Nencetti S; Demontis GC; Mazzoni MR; Betti L; Banti I; Rossello A; Lapucci A
    J Pharm Pharmacol; 2007 Oct; 59(10):1439-45. PubMed ID: 17910821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.